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DOI 10.1016/j.chom.2010.02.002We are most pleased Statnikov et al.
(2010) could utilize the gene-expression
data from Zaas et al. (Zaas et al., 2009)
to develop a similar gene-expression
signature for viral infection. It is not sur-
prising that microarray data can result in
predictors that are not unique and that
can offer signatures of comparable pre-
dictive performance. Ein-Dor et al. (2005)
identified at least eight separate gene
sets whose expression patterns stratify
the same patient into comparable risk
categories for breast cancer suggesting
that there are multiple forms of informa-
tion in a single data set that can equally
well stratify patients. The fundamental
reason is the diversity, scale, and com-
plexity of genomic factors defining the
disease state.
We appreciate Stanlikov et al.’s
suggestions for improving the analysis
and respond below in order of the sug-
gestions. First, genes were selected
based on coherent expression across
the entire data set. Fitting the factormodel
was done without regard to phenotype.
The appropriate factor from which to
select genes was clear regardless of the
samples used in cross-validation. Genes
were selected and the model was built
on the training data set only. Second,102 Cell Host & Microbe 7, February 18, 2010it is possible that the gene-expression
patterns at baseline are predictive of
symptomatic versus asymptomatic at
the time of maximum symptoms (T). If
this were the case, however, the effect
would work against our ability to generate
amodel to distinguish between symptom-
atic and asymptomatic or the baseline
healthy state. Thus, we are able to distin-
guish symptomatic from asymptomatic/
baseline despite rather than because of
any effect linking samples from baseline
and T. Third, our analysis was purely
unsupervised—no use of the phenotype
data was made in the process of fitting
the factor models. Part of the hierarchical
structure of the Bayesian model includes
the estimation of factor size, which is the
proper technique for accounting for false
discovery in this context. The choice of
30 genes was arbitrary but this choice
does not in any way lessen the value of
the result. Our goal was to present a
gene set in the factors that might be
amenable to a clinical assay such as RT
PCR. Fourth, Statnikov et al. are correct
that only one of the three viruses were in
Ramilo et al. (2007). However, the goal
of this aspect of our analysis was to
show that the ‘‘acute respiratory viral
signature’’ could identify one of the rele-ª2010 Elsevier Inc.vant viruses in the training set. Moreover,
the Ramilo data set was generated on an
independent microarray platform from
that of ours. The fact that we could
achieve such a good validation speaks
to the robust nature of our acute respira-
tory signature. It should also be noted
that we did treat each of the viral data
sets as validations of the other (closer to
‘‘apples to apples’’), and we are not aware
of the existence of any public data set that
is more appropriate for validation than
Ramilo. Fifth, our work was not designed
to demonstrate a complete analysis of
the data, but rather to demonstrate the
possibility of distinguishing infectious
agents based on host response.
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